Baby brain scan could revolutionize hearing tests

NCT ID NCT06406088

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a device called EarGenie that uses light to measure brain activity in babies while they listen to sounds. The goal was to see if it could accurately detect whether infants can hear and tell sounds apart. The trial included 10 normal-hearing babies aged 1-24 months, but was terminated early.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

EarGenie MVP test (device using fNIRS to measure brain responses to sound)

What this could lead to

If successful, this could lead to a simple, non-invasive hearing test for babies that doesn't require them to respond actively.

What could go wrong

This was a small, early-stage trial that was terminated, so results are limited. The device may not be accurate enough for real-world use.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEARING IMPAIRED CHILDREN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hearing loss disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Bionics Institute

    Fitzroy, Victoria, 3065, Australia